| Withdrawn | Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carbopla Extensive-stage Small Cell Lung Cancer | Phase 3 | 2012-08-01 |
| Completed | A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users Drug Abuse | Phase 1 | 2012-03-01 |
| Completed | Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability Cancer, Pain | — | 2011-07-01 |
| Completed | Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mant Solid Tumors or Mantle Cell Lymphoma | Phase 1 | 2011-05-01 |
| Completed | A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects Wi Hepatic Impairment | Phase 1 | 2011-04-01 |
| Completed | A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Renal Impairment | Phase 1 | 2011-03-01 |
| Completed | Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adult Depression | Phase 3 | 2011-03-01 |
| Completed | Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidura Sciatica | Phase 1 / Phase 2 | 2011-01-01 |
| Terminated | Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Bone Loss, Osteoporosis | Phase 1 | 2010-07-01 |
| Completed | Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Pre Non-Hodgkin's Lymphoma (NHL) | Phase 2 | 2010-05-01 |
| Terminated | Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression | Phase 3 | 2010-04-30 |
| Completed | Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disord Excessive Sleepiness | Phase 4 | 2010-03-01 |
| Completed | Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression | Phase 3 | 2010-03-01 |
| Completed | Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Pati Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma | Phase 3 | 2010-02-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Majo Depression | Phase 3 | 2010-01-01 |
| Terminated | Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) i Multiple Myeloma | Phase 1 / Phase 2 | 2010-01-01 |
| Completed | Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymp Mantle Cell Lymphoma | Phase 2 | 2009-06-01 |
| Completed | Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2009-06-01 |
| Completed | Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanc Solid Tumor | Phase 1 | 2009-06-01 |
| Completed | Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy Malignancy | Phase 1 | 2009-05-01 |
| Terminated | Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tol Cancer Pain, Breakthrough Pain | Phase 4 | 2009-01-01 |
| Completed | Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain Chronic Pain | Phase 3 | 2008-12-01 |
| Terminated | Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agen Fatigue, Chemotherapy Side Effects | Phase 2 | 2008-12-01 |
| Completed | Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia Schizophrenia | Phase 2 | 2008-09-01 |
| Completed | Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Excessive Sleepiness | Phase 3 | 2008-09-01 |
| Completed | Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Perform Excessive Sleepiness | Phase 4 | 2008-09-01 |
| Completed | Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis Polycythemia Vera, Essential Thrombocytosis | Phase 2 | 2007-12-01 |
| Completed | Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and D Sleep Disorders, Obstructive Sleep Apnea, Major Depressive Disorder | Phase 4 | 2007-10-01 |
| Terminated | Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Le Acute Myeloid Leukemia | Phase 3 | 2007-10-01 |
| Completed | Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients Wi Cancer | Phase 1 | 2007-09-01 |
| Completed | Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits Schizophrenia | Phase 2 | 2007-07-01 |
| Completed | Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pai Chronic Pain | Phase 3 | 2007-07-01 |
| Completed | Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder Bipolar I Depression | Phase 2 | 2007-06-01 |
| Terminated | Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms Whe Pain, Chronic Pain, Breakthrough Pain | Phase 3 | 2006-12-01 |
| Completed | Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain Pain, Cancer, Sickle Cell Anemia | Phase 2 | 2006-10-01 |
| Completed | Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Break Pain | Phase 3 | 2006-08-01 |
| Completed | Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorde Attention Deficit Hyperactivity Disorder | Phase 3 | 2006-06-01 |
| Completed | Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD Attention Deficit Hyperactivity Disorder, ADHD | Phase 2 | 2006-05-01 |
| Terminated | Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma Myeloma | Phase 2 | 2006-04-01 |
| Completed | Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With N Excessive Daytime Sleepiness, Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) | Phase 3 | 2005-10-01 |
| Completed | Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Non-Hodgkin's Lymphoma | Phase 3 | 2005-10-01 |
| Completed | Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain Chronic Low Back Pain | Phase 3 | 2005-09-01 |
| Completed | Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pa Chronic Neuropathic Pain | Phase 3 | 2005-09-01 |
| Completed | Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD ADHD | Phase 3 | 2005-09-01 |
| Completed | Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL Chronic Shift Work Sleep Disorder | Phase 3 | 2005-08-01 |
| Completed | Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis Psoriasis | Phase 2 | 2005-06-01 |
| Completed | Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Rela Low Back Pain, Migraine, Diabetic Neuropathies | Phase 3 | 2005-03-01 |
| Completed | Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepines Narcolepsy | Phase 3 | 2005-01-01 |
| Completed | Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder. Anxiety Disorders | Phase 3 | 2005-01-01 |
| Completed | Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients Pain, Cancer | Phase 3 | 2005-01-01 |
| Completed | A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder Anxiety Disorder | Phase 3 | 2004-11-01 |
| Completed | PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolep Narcolepsy, Sleep Apnea, Obstructive | Phase 3 | 2004-10-01 |
| Completed | Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated Wit Sleep Apnea, Obstructive | Phase 3 | 2004-10-01 |
| Completed | A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disord Generalized Anxiety Disorder | Phase 3 | 2004-10-01 |
| Completed | A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Generalized Anxiety Disorder | Phase 3 | 2004-10-01 |
| Completed | Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated Wit Narcolepsy | Phase 3 | 2004-10-01 |
| Terminated | Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, Chronic Lymphocytic Leukemia | Phase 2 | 2004-09-01 |
| Completed | Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain Breakthrough Pain | Phase 3 | 2004-06-01 |
| Completed | Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepine Excessive Daytime Sleepiness, Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome | Phase 3 | 2004-05-01 |
| Completed | OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients Pain, Cancer | Phase 3 | 2004-04-01 |
| Completed | SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma | Phase 2 | 2004-04-01 |
| Completed | Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP) Cancer, Breakthrough Pain | Phase 2 | 2004-04-01 |
| Completed | Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Obstructive Sleep Apnea, Sleep Hypopnea | Phase 3 | 2004-03-01 |
| Completed | Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy | Phase 3 | 2004-03-01 |
| Completed | Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chroni Excessive Sleepiness, Shift Work Sleep Disorder | Phase 3 | 2004-03-01 |
| Completed | Study of CEP-701 in Treatment of Prostate Cancer Prostate Cancer | Phase 2 | 2004-03-01 |
| Completed | Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Obstructive Sleep Apnea, Hypopnea | Phase 3 | 2004-02-01 |
| Completed | Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shi Narcolepsy, Sleep Apnea, Obstructive, Sleep Apnea Syndromes | Phase 3 | 2004-01-01 |
| Completed | Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia | Phase 2 | 2003-10-01 |
| Completed | Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma | Phase 2 | 2003-09-01 |
| Completed | Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD Attention Deficit/Hyperactivity Disorder, ADHD | Phase 3 | 2003-09-01 |
| Completed | Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder General Anxiety Disorder | Phase 3 | 2003-08-01 |
| Terminated | Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease Parkinson Disease | Phase 2 / Phase 3 | 2002-03-01 |
| Terminated | Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM) Multiple Myeloma | Phase 2 | 2002-02-01 |
| Completed | Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation Leukemia, Myeloid | Phase 2 | 2002-01-01 |